Role of nitric oxide in diabetic nephropathy

Seminars in Nephrology

Volumn 24, Issue 4, 2004, Pages 333-344

  Prabhakar, Sharma S ^a  

^a TEXAS TECH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANGIOTENSIN; GLUCOSE; INSULIN; ISOENZYME; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN KINASE C; TRANSFORMING GROWTH FACTOR BETA;

DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE SEVERITY; ENDOTHELIUM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; GENETIC POLYMORPHISM; GLOMERULUS FILTRATION; HEMODYNAMICS; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FUNCTION; METABOLISM; MICROALBUMINURIA; NERVE CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEINURIA; RESPIRATORY BURST; REVIEW; STRESS;

EID: 3142564598     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2004.04.005     Document Type: Article

References (107)

1. Baylis C., Mitruka B., Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest. 90:1992;278-281
2. Narita I., Border W.A., Ketteler M., et al. L-arginine may mediate the therapeutic effects of low protein diets. Proc Natl Acad Sci U S A. 9:1995;4552-4556
3. Wardle E.N. How does hyperglycemia predispose to diabetic nephropathy? QJM. 90:1997;493
4. Verbeke P., Perichon M., Friguet B., et al. Inhibition of nitric oxide synthase activity by early and advanced glycation end products in cultured rabbit proximal tubular epithelial cells. Biochim Biophys Acta. 1502:2000;481-494
5. Du X.L., Edelstein D., Dimmeler S., et al. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest. 108:2001;1341-1348
6. Craven P.A., Studer R.K., DeRubertis F.R. Impaired nitric oxide release by glomeruli from diabetic rats. Metabolism. 44:1995;695-698
7. Craven P.A., Studer R.K., DeRubertis F.R. Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. Evidence for protein kinase C-mediated suppression of cholinergic response. J Clin Invest. 93:1994;311-320
8. Dai F.X., Diederich A., Skopec J., et al. Diabetes-induced endothelial dysfunction in streptozotocin-treated rats Role of prostaglandin endoperoxides and free radicals. J Am Soc Nephrol. 4:1993;1327-1336
9. Schnackenberg C.G., Wilcox C.S. The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetes. Kidney Int. 59:2001;1859-1864
10. Ohishi K., Carmines P.K. Superoxide dismutase restores the influence of nitric oxide on renal arterioles in diabetes mellitus. J Am Soc Nephrol. 5:1995;1559-1566
11. Trachtman H., Futterweit S., Crimmins D.L. High glucose inhibits nitric oxide production in cultured rat mesangial cells. J Am Soc Nephrol. 8:1997;1276-1282
12. Prabhakar S.S. Tetrahydrobiopterin reverses the inhibition of nitric oxide by high glucose in cultured murine mesangial cells. Am J Physiol. 281:2001;F179-F188
13. Sharma K., Danoff T.M., DePiero A., et al. Enhanced expression of inducible nitric oxide synthase in murine macrophages and glomerular mesangial cells by elevated glucose levels Possible mediation via protein kinase C. Biochem Biophys Res Commun. 6:1995;80-88
14. Noh H., Ha H., Yu M.R., et al. High glucose increases inducible NO production in cultured rat mesangial cells. Possible role in fibronectin production. Nephron. 90:2002;78-85
15. Hink U., Li H., Mollnau H., et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res. 88:2001;E14-E22
16. Brodsky S.V., Morrishow A.M., Dharia N., et al. Glucose scavenging of nitric oxide. Am J Physiol. 280:2001;F480-F486
17. Trachtman H., Koss I., Bogart M., et al. High glucose enhances growth factor-stimulated nitric oxide production by cultured rat mesangial cells. Res Commun Mol Pathol Pharmocol. 100:1998;213-225
18. Trachtman H., Futterweit S., Franki N., et al. Effect of vascular endothelial growth factor on nitric oxide production by cultured rat mesangial cells. Biochem Biophys Res Commun. 245:1998;443-446
19. Kasai N., Sugimoto K., Horiba N., et al. Effect of D'glucose on nitric oxide release from glomerular endothelial cells. Diabetes Metab Rev. 17:2001;217-222
20. Amore A., Cirina P., Mitola S., et al. Nonenzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells. Kidney Int. 51:1997;27-35
21. Sugimoto H., Shikata K., Matsuda M., et al. Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy. Diabetologia. 41:1998;1426-1434
22. Wautier J.L., Guillausseau P.J. Advanced glycation end products, their receptors and diabetic angiopathy. Diabetes Metab. 27:2001;535-542
23. Rojas A., Romay S., Gonzales D., et al. Regulation of eNOS expression by albumin derived advanced glycation end-products. Circ Res. 86:2000;E50-E54
24. Goligorsky M.S., Chen J., Brodsky S., et al. Workshop: Endothelial cell dysfunction leading to diabetic nephropathy: Focus on nitric oxide. Hypertension. 37:2001;744-748
25. Chakravarthy U., Hayes R.G., Stitt A.W., et al. Constitutive NOS expression in retinalvascular endothelial cells is suppressed by high glucose and advanced glycation end-products. Diabetes. 47:1998;945-952
26. Bucala R., Tracey K.J., Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest. 87:1991;432-438
27. Hogan M., Cerami A., Bucala R. Advanced glycosylation end products block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus. J Clin Invest. 90:1992;1110-1115
28. Scivittaro V., Ganz M.B., Weiss M.F. AGEs induce oxidative stress and activate protein kinase C-beta(II) in neonatal mesangial cells. Am J Physiol. 278:2000;F676-F683
29. Choi K.C., Kim N.H., An M.R., et al. Alterations of intrarenal renin-angiotensin and nitric oxide systems in streptozotocin-induced diabetic rats. Kidney Int. 52:(suppl 60):1997;S23-S27
30. De Vriese A.S., Stoenoiu M.S., Elger M., et al. Diabetes-induced microvascular dysfunction in the hydronephrotic kidney Role of nitric oxide. Kidney Int. 60:2001;202-210
31. Veelken R., Hilgers K.F., Hartner A., et al. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy. J Am Soc Nephrol. 11:2000;71-79
32. Ishii N., Patel K.P., Lane P.H., et al. Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. J Am Soc Nephrol. 12:2001;1630-1639
33. Omer S., Shan J., Varma D.R., et al. Augmentation of diabetes-associated renal hyperfiltration and nitric oxide production by pregnancy in rats. J Endocrinol. 161:1999;15-23
34. Keynan S., Hirshberg B., Levin-Iaina N., et al. Renal nitric oxide production during the early phase of experimental diabetes mellitus. Kidney Int. 58:2000;740-747
35. Wilcox C.S., Welch W.J., Murad F., et al. Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci U S A. 89:1992;11993-11997
36. Sugimoto H., Shikata K., Wada J., et al. Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of 1diabetic nephropathy Aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli. Diabetologia. 42:1999;878-886
37. Schwartz D., Schwartz I.F., Blantz R.C. An analysis of renal nitric oxide contribution to hyperfiltration in diabetic rats. J Lab Clin Med. 137:2001;107-114
38. Komers R., Oyama T.T., Chapman J.G., et al. Effects of systemic inhibition of neuronal nitric oxide synthase in diabetic rats. Hypertension. 34:2000;655-661
39. Komers R., Lindsley J.N., Oyama T.T., et al. Role of neuronal nitric oxide synthase (NOS1) in the pathogenesis of renal hemodynamic changes in diabetes. Am J Physiol. 279:2000;F573-F583
40. Ito A., Uriu K., Inada Y., et al. Inhibition of neuronal nitric oxide synthase ameliorates renal hyperfiltration in streptozotocin-induced diabetic rat. J Lab Clin Med. 138:2001;177-185
41. Komers R., Anderson S. Paradoxes of nitric oxide in the diabetic kidney. Am J Physiol. 284:2003;F1121-F1137
42. Cosenzi A., Bernobich E., Bonavita M., et al. Role of nitric oxide in the early renal changes induced by high fructose diet in rats. Kidney Blood Press Res. 25:2002;363-369
43. Soulis T., Cooper M.E., Sastra S., et al. Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine- mediated renoprotection in diabetic rats. Diabetologia. 40:1997;1141-1151
44. Nishio E., Watanabe Y. Glucose-induced down-regulation of NO production and inducible NOS expression in cultured rat aortic vascular smooth muscle cells Role of protein kinase C. Biochem Biophys Res Commun. 24:1996;857-863
45. Guo X., Chen L.W., Liu W.L., et al. High glucose inhibits expression of inducible and constitutive nitric oxide synthase in bovine aortic endothelial cells. Acta Pharmacol Sin. 21:2000;325-328
46. Begum N., Ragolia L. High glucose and insulin inhibit VSMC MKP-1 expression by blocking iNOS via p38 MAPK inactivation. Am J Physiol. 278:2000;C81-C91
47. Trachtman H., Futterweit S., Pine E., et al. Chronic diabetic nephropathy Role of inducible nitric oxide synthase. Pediatric Nephrol. 17:2002;20-29
48. King A.J., Troy J.L., Anderson S., et al. Nitric oxide A potential mediator of amino acid-induced renal hyperemia and hyperfiltration. J Am Soc Nephrol. 1:1991;1271-1277
49. Tolins J.P., Shultz P.J., Raij L., et al. Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats Role of NO. Am J Physiol. 265:1993;F886-F895
50. Komers R., Allen T.J., Cooper M.E. Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes. Diabetes. 43:1994;1190-1197
51. Bank N., Aynedjian H.S. Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int. 43:1993;1306-1312
52. Mattar A.L., Fujihara C.K., Ribeiro M.O., et al. Renal effects of acute and chronic nitric oxide inhibition in experimental diabetes. Nephron. 74:1996;136-143
53. Goor Y., Peer G., Iaina A., et al. Nitric oxide in ischaemic acute renal failure of streptozotocin diabetic rats. Diabetologia. 39:1996;1036-1040
54. G-nitro-L-arginine methyl ester on regional haemodynamics in conscious rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol. 103:1991;1321-1326
55. Pflueger A.C., Larson T.S., Hagl S., et al. Role of nitric oxide in intrarenal hemodynamics in experimental diabetes mellitus in rats. Am J Physiol. 277:1999;R725-R733
56. Pflueger A.C., Larson T.S., Hagl S., et al. Role of nitric oxide in intrarenal hemodynamics in experimental diabetes mellitus in rats. Am J Physiol. 277:1999;R725-R733
57. Wang Y.X., Brooks D.P., Edwards R.M. Attenuated glomerular cGMP production and renal vasodilation in streptozotocin-induced diabetic rats. Am J Physiol. 264:1993;R952-R956
58. Craven P.A., DeRubertis F.R., Melhem M. Nitric oxide in diabetic nephropathy. Kidney Int. 52:(suppl 60):1997;S46-S53
59. Wessels J., Peake P., Pussell B.A., et al. Nitric oxide synthase inhibition in a spontaneously hypertensive rat model of diabetic nephropathy. Clin Exp Pharmacol Physiol. 24:1997;451-453
60. Reyes A.A., Karl I.E., Kissane J., et al. L-arginine administration prevents glomerular hyperfiltration and decreases proteinuria in diabetic rats. J Am Soc Nephrol. 4:1993;1039-1045
61. Lubec B., Aufricht C., Amann G., et al. Arginine reduces kidney collagen accumulation, cross-linking, lipid peroxidation, glycoxidation, kidney weight and albuminuria in the diabetic kk mouse. Nephron. 75:1997;213-218
62. Fujihara C.K., De-Nucci G., Zatz R. Chronic nitric oxide synthase inhibition aggravates glomerular injury in rats with subtotal nephrectomy. J Am Soc Nephrol. 5:1995;1498-1507
63. Klahr S. Can L-arginine manipulation reduce renal disease? Semin Nephrol. 19:1999;304-309
64. Hiragushi K., Sugimoto H., Shikata K., et al. Nitric oxide system is involved in glomerular hyperfiltration in Japanese normo- and micro-albuminuric patients with type 2 diabetes. Diabetes Res Clin Pract. 53:2001;149-159
65. Dalla Vestra M., Sacerdoti D., Bombonato G., et al. Nitric oxide modulation of renal and cardiac hemodynamics in type 2 diabetes. Eur J Endocrinol. 146:2002;687-694
66. Earle K.A., Mehrotra S., Dalton R.N., et al. Defective nitric oxide production and functional renal reserve in patients with type 2 diabetes who have microalbuminuria of African and Asian compared with white origin. J Am Soc Nephrol. 12:2001;2125-2130
67. Maejima K., Nakano S., Himeno M., et al. Increased basal levels of plasma nitric oxide in type 2 diabetic subjects. Relationship to microvascular complications. J Diabetes Complications. 15:2001;135-143
68. Yamada K., Nakano H., Nakayama M., et al. Endothelium-dependent relaxation in peripheral vasculature and kidney of non-insulin-dependent diabetes mellitus. J Diabetes Complications. 9:1995;203-207
69. Frauchiger B., Nussbaumer P., Hugentobler M., et al. Duplex sonographic registration of age and diabetes-related loss of renal vasodilatory response to nitroglycerine. Nephrol Dial Transplant. 15:2000;827-832
70. Thuraisingham R.C., Nott C.A., Dodd S.M., et al. Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy. Kidney Int. 57:2000;1968-1972
71. Asakimori Y., Yorioka N., Yamamoto I., et al. Endothelial nitric oxide synthase intron 4 polymorphism influences the progression of renal disease. Nephron. 89:2001;219-223
72. Negebauer S., Baba T., Watanabe T. Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Diabetes. 49:2000;500-503
73. Wang Y., Kikuchi S., Suzuki H., et al. Endothelial nitric oxide synthase gene polymorphism in intron 4 affects the progression of renal failure in non-diabetic renal diseases. Nephrol Dial Transplant. 14:1999;2898-2902
74. Zhang C., Mayeux P. Angiotensin II signaling activities the NO-cGMP pathway in rat proximal tubules. Life Sci. 63:1998;75-80
75. Moreno C., Lopez A., Llinas M.T., et al. Changes in NOS activity and protein expression during acute and prolonged ANG II administration. Am J Physiol. 282:2002;R31-R37
76. Hennington B., Zhang H., Miller M., et al. Angiotensin II stimulates synthesis of endothelial nitric oxide synthase. Hypertension. 31:1998;283-288
77. Zou A., Wu F., Cowley A. Protective effect of angiotensin II induced increase in nitric oxide in renal medullary circulation. Hypertension. 31:1998;271-276
78. Thorup C., Kornfeld M., Winaver J., et al. Angiotensin II stimulates nitric oxide release in isolated perfused renal arteries. Pflugers Arch. 435:1998;432-434
79. Kihara M., Yabana M., Toya Y., et al. Angiotensin II inhibits interleukin-1β induced nitric oxide production in cultured rat mesangial cells. Kidney Int. 55:1999;1277-1283
80. Wolf G., Ziyadeh F., Schroeder R., et al. Angiotensin II inhibits inducible nitric oxide synthase in tubular MCT cells by a posttranscriptional mechanism. J Am Soc Nephrol. 8:1997;551-557
81. Nakayama I., Kawahara Y., Okuda M., et al. Angiotensin II type 1 receptor-mediated inhibition of cytokine-stimulated inducible nitric oxide synthase expression in vascular smooth muscle cells. Blood Press. 5:(Suppl):1994;32-37
82. Onozato M.L., Tojo A., Fujita T., et al. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy Effects of ACEI and ARB. Kidney Int. 61:2002;186-194
83. Forbes J.M., Cooper M.E., Thallas V., et al. Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. Diabetes. 51:2002;3274-3282
84. Schmetterer L., Muller M., Fasching P., et al. Renal and ocular hemodynamic effects of insulin. Diabetes. 46:1997;1868-1874
85. Komers R., Pelikanova T., Kazdova L. Effect of hyperinsulinemia on renal function and nitrate/nitrite excretion in healthy subjects. Clin Exp Pharmacol Physiol. 26:1999;336-341
86. Prabhakar S.S. Insulin stimulates inducible nitric oxide synthesis in normal human mesangial cells by augmenting cellular uptake of L-arginine. Nephrol Dial Transplant. 18:2003;49
87. Smukler S.R., Tang L., Wheeler M.B., et al. Exogenous nitric oxide and endogenous glucose-stimulated beta-cell nitric oxide augment insulin release. Diabetes. 51:2002;3450-3460
88. Prabhakar S.S. Role of nitric oxide in the regulation of insulin secretion by pancreatic islet cells. J Am Soc Nephrol. 14:2003;323A
89. Derubertis F.R., Craven P.A. Activation of protein kinase C in glomerular cells in diabetes. Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes. 43:1994;1-8
90. McCarty M.F. A central role for protein kinase C overactivity in diabetic glomerulosclerosis Implications for prevention with antioxidants, fish oil, and ACE inhibitors. Med Hypotheses. 50:1998;155-165
91. Michell B.J., Chen Z.P., Tiganis T., et al. Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem. 25:2001;17625-17628
92. Sharma K., Ziayadh F.N., Alzahabi B., et al. Increased renal production of TGF-beta 1 in patients with type II diabetes mellitus. Diabetes. 46:1997;854-859
93. Chen S., Jim B., Ziyadeh F.N. Diabetic nephropathy and transforming growth factor-beta Transforming our view of glomerulosclerosis and fibrosis build-up. Semin Nephrol. 23:2003;532-543
94. Kagami S., Border W.A., Miller D.E., et al. Angiotensin II stimulates extracellular matrix protein synthesis through induction of TGF-beta expression in rat glomerular mesangial cells. J Clin Invest. 93:1994;2431-2437
95. Wang S., Shiva S., Poczatek M.H., et al. Nitric oxide and cGMP-dependent protein kinase regulation of glucose-mediated thrombospondin 1-dependent transforming growth factor-beta activation in mesangial cells. J Biol Chem. 277:2002;9880-9888
96. Agarwal R., Siva S., Dunn S.R., et al. Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels. Am J Kidney Dis. 39:2002;486-492
97. Asakimori Y., Yorioka N., Taniguchi Y., et al. T)-786)->C polymorphism of the endothelial nitric oxide synthase gene influences the progression of renal disease. Nephron. 91:2002;747-751
98. Suzuki H., Nagase S., Kikuchi S., et al. Association of a missense Glu298Asp mutation of the endothelial nitric oxide synthase gene with end stage renal disease. Clin Chem. 46:2000;1858-1860
99. Cai H., Wang X., Colagiuri S., et al. A common Glu298->Asp (894G->T) mutation at exon 7 of the endothelial nitric oxide synthase gene and vascular complications in type 2 diabetes. Diabetes Care. 21:1998;2195-2196
100. Noiri E., Satoh H., Taguchi J., et al. Association of eNOS Glu298Asp polymorphism with end stage renal disease. Hypertension. 40:2002;535-540
101. Li C., Dong Y., Lu W. The association between polymorphism of endothelial nitric oxide synthase gene and diabetic nephropathy. Zhonghua Nei Ke Za Zhi. 40:2001;729-732
102. Freedman B.I., Yu H., Anderson P.J., et al. Genetic analysis of nitric oxide and endothelin in end-stage renal disease. Nephrol Dial Transplant. 15:2000;1794-1800
103. Fujita H., Narita T., Meguro H., et al. Lack of association between an ecNOS gene polymorphism and diabetic nephropathy in type 2 diabetic patients with proliferative diabetic retinopathy. Horm Metab Res. 32:2000;80-83
104. Shimizu T., Onuma T., Kawamori R., et al. Endothelial nitric oxide synthase gene and the development of diabetic nephropathy. Diabetes Res Clin Pract. 58:2002;179-185
105. Rippin J.D., Patel A., Belyaev N.D., et al. Nitric oxide synthase gene polymorphisms and diabetic nephropathy. Diabetologia. 46:2003;426-428
106. Zanchi A., Moczulski D.K., Hanna L.S., et al. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int. 57:2000;405-413
107. Johannesen J., Tarnow L., Parving H.H., et al. CCTTT-repeat polymorphism in the human NOS2- promoter confers low risk of diabetic nephropathy in type 1 diabetic patients. Diabetes Care. 23:2000;560-562